Blood tests could reveal how immunotherapy works inside cancer patients

NCT ID NCT07260370

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking at tiny particles in the blood called microRNA and circulating tumor cells in 300 cancer patients who are about to start immunotherapy. By comparing blood samples taken before and after treatment, researchers hope to see how these markers change. The goal is to better understand how immunotherapy affects the body, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm Neoplastic Cells, Circulating

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Linkou Chang Gung Memorial Hospital

    RECRUITING

    Taoyuan City, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••